LONDON (Reuters) - Sanofi's new Toujeo diabetes drug is on track to receive a potential green light from European regulators this week, building on a U.S. regulatory approval awarded on Wednesday.
via Reuters: Health News Read More Here..
No comments:
Post a Comment